May 4 to 6, 2008
• The Great Wall Sheraton Hotel Beijing - Chaoyang District, Beijing,
Conference Sponsors & Exhibitors
PLATINUM LUNCH SPONSOR
Mayer Brown is a leading global law firm with offices in key business centers across the Americas, Europe and Asia. We have approximately 1,000 lawyers in the Americas, 300 in Asia and 500 in Europe. The firm's Asia presence was enhanced by its 2008 combination with Johnson Stokes & Master, the largest and oldest Asia law firm. This unequalled on-the-ground presence in the world’s leading markets for legal services enables Mayer Brown to offer access to local market expertise on a global basis.
Mayer Brown is noted for its commitment to client service and its ability to assist clients with their most complex and demanding legal and business challenges world-wide. The firm serves many of the world’s largest companies, including a significant proportion of the Fortune 100, FTSE 100 and DAX companies and more than half of the world's largest investment banks. Please visit our website at www.mayerbrown.com/biotech.
Medidata Solutions is a leading provider of clinical trial solutions that enable the world’s most advanced life science organizations to maximize the value of their clinical research investments. A pioneer since 1999 in innovative technologies to optimize clinical research processes – protocol design; clinical data capture, management and reporting; and trial planning and negotiation – Medidata Solutions addresses the unique needs of sponsors and sites of all sizes, bringing deep clinical experience and expertise in conducting studies across all phases and therapeutic areas, on six continents and in more than 80 countries.
Beijing Development Area is a state-level economic and technological development area in Beijing.
Now BDA has attracted a large number of high-grade, high value-added, low energy consumption and pollution hi-tech industries. More than 2,300 enterprises coming from more than 30 countries and regions all over the world(70 projects were invested by Fortune 500 enterprises) have settled down in the BDA. Presently, such leading industries as electronic information, biological technology and new medicine, auto industry, equipment manufacture, etc. represented by these internationally noted brands as SMIC, NOKIA, GE, Bayer, BOE, Benz-DaimlerChrysler, etc. .
Bridge Laboratories is a US-owned, preclinical contract research organization (CRO) that provides US-level regulatory compliant drug development services globally. Bridge is headquartered in Gaithersburg, Maryland, with lab facilities in the US and Beijing, China. Bridge is known for its extensive work in toxicology; including vaccines, developmental and reproductive toxicology, and safety pharmacology. Bridge’s AAALAC accredited facility in China was among the first labs to perform GLP studies for clients worldwide.
Bridge Laboratories differs from other CROs by being extremely flexible and customer-centric, with an innovative spirit and “can-do” attitude that begins with top management and carries through all employees in all departments. Bridge’s high number of experienced staff also ensures that their clients consistently get the top study directors working on their projects. Thus Bridge is able to provide clients with rapid study start scenarios, dynamic scheduling options to meet key client milestones, high quality studies and reports, flexibility and accessibility throughout the process, and on-time follow-through with results.
VPS CRO, a member of Venturpharm group, is the No 1 CRO for Global Specialty pharma and biotech company in china with respective of both clinical trial and pre-clinical studies. Selected as The 2002 Top Ten management company in China and the 2007 Frost & Sullivan Award: Best CRO in Asia: Competitive Strategy Leadership
-Only Public listed company in these areas
- Largest CRO in term of No. of on going trials and No. of CRAs
- Leader on therapy: Oncology, CV, CNS and HIV
- Leader on Data management
- Leader on IV studies and clinical marketing service
- No 1 on Regulatory affair: filing over 400 projects for last 8 years in China
Quintiles is the global leader in pharmaceutical services, improving healthcare worldwide by providing innovative, quality professional expertise, market intelligence and partnering solutions to meet the dynamic needs of the pharmaceutical, biotechnology and healthcare industries. Quintiles has over 18,000 specialized employees and offices in 53 countries.
Quintiles Asia Pacific has clinical development offices in 13 countries. Since 1993, the Quintiles clinical team in Asia Pacific has completed over 600 clinical trials involving about 3,500 sites and more than 80,000 patients.
Quintiles East Asia Pte Ltd was established in 1995 in Singapore as a wholly owned subsidiary of Quintiles Transnational Corporation and today operates throughout the Asia-Pacific region. It offers the full spectrum of clinical development services, including clinical research, laboratory services, regulatory affairs and consulting to pharmaceutical and biotechnology firms.
Quintiles offers services in diverse therapeutic areas including Central Nervous System (CNS), Oncology, Cardiovascular, Thrombosis, Respiratory, Urology, Autoimmune, Endocrinology and Infectious diseases. Quintiles in Asia also enjoys unparalleled geographic reach. In 2005, Quintiles set up offices in Indonesia and Vietnam, adding to its established operations in Australia, New Zealand, Malaysia, Philippines, Taiwan, Korea, Singapore, Thailand, India China, and Hong Kong. In addition, we operate central laboratory facilities in Singapore, China and India.
In short, Quintiles has the resources and the right approach to deliver excellent results for small and large projects every step of the way, in Asia and virtually anywhere in the world, bringing true value to clinical development investments.
For more information, please refer to www.quintiles.com
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Headquartered near Boston, Massachusetts, PAREXEL operates in 64 locations throughout 51 countries around the world, and has more than 7,500 employees
PAREXEL APEX International is a leading CRO in Asia operating in 13 locations across the Asian Pacific region and officially became part of PAREXEL International on September 26, 2007. With expanded capabilities and well-rounded operation, we look forward in providing our clients worldwide with the best possible solutions and valuable insight into the clinical and commercial potential of new products.
BRONZE SPONSOR
The Leading CRO in China
Excel PharmaStudies (www.excel-china.com) is the leading full service clinical research organization in China. Our main office is in Beijing with one office in San Francisco, one in Cologne and eleven branches throughout China.
In the last several years, Excel has conducted 150 trials involving 25 therapeutic areas with about 50,000 patients and obtained 213 regulatory approvals. Our biometrics service is moving toward FDA 21 CFR, PART 11 standard. Excel has strong medical, regulatory and biometrics teams. Our clients include most of the top 50 international pharmaceutical, biotech and medical device companies
EPS Group was established in 1991 and over the past 17 years has thrived to become one of the largest CROs in Asia. The latest member, EPS International, has access to the groups team of over 1800 experts fully trained in ICH/GCP with experience in over 1200 projects, able to offer top quality clinical trial services across the whole of Asia.
Flexible and precise with a dedication to excellence, that is second to none.
Lovells is a leading international legal practice with over 350 partners and 1,600 lawyers worldwide. In Asia, we have over 150 lawyers in offices in Beijing, Hong Kong, Ho Chi Minh City, Shanghai, Singapore and Tokyo.
Lovells has one of the largest and most highly integrated intellectual property practices in the world and consistently ranked as one of the best in Asia and Europe. We handle intellectual property matters for a broad range of clients in a wide range of industry sectors, including pharmaceuticals, health-care products, biotechnology, chemicals and plastics, electrical, mechanical and engineering, computer software, semi-conductors, telecommunications, electronics and digital systems.
Marken is a transportation specialist offering global time sensitive delivery solutions to its customers worldwide. Leveraging global resources, advanced information technology and industry focused expertise our solutions are tailor made to the needs of our customers.
Marken over the years has offered transport services to many pharmaceutical and biotechnology companies along with the most important CRO’s and central laboratories. We handle and transport biological samples during all phases of clinical trials whether they be infectious, diagnostic, ambient or on dry ice. A number of the services we provide for the pharmaceutical industry include clinical supply and investigational drug shipping, clinical trial co-ordination, recommendation and furnishing of packaging materials, ongoing site support and provision and replenishment of dry ice on a global basis.
MDS Pharma Services (www.mdsps.com) is committed to delivering quality service on-time. We offer a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process – from lead optimization, pre-IND research, early stage development: clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company.
As a subsidiary of MicroConstants Inc. of San Diego, California, which has been providing discovery DMPK and GLP bioanalysis contact service over the last ten years, MicroConstants China has adopted all the SOPs and GLP management system from MicroConstants Inc. While providing discovery PK studies in rodents, dog and non-human primate, the Company’s goal is to be FDA GLP compliance by the end of year 2008.
Paramax International Inc. (www.paramaxinternational.com) is a contract research organization in the U.S. and China providing a wide range of professional services to biopharma and medical device companies worldwide.
Since its inception in the U.S. in January 2003, we have worked successfully with many international biopharma and medical device companies. We have established offices in Beijing and Shanghai in China to provide our clients with a full range of services that include clinical monitoring, project management, regulatory affairs, medical writing, clinical data management and biostatistics, Chinese market entry consulting, animal toxicology and pharmacology. We look forward to providing you with unparalleled service and expertise for all of your clinical trial needs. Please contact us at 8610 6561 0216.
The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the clinical research organization (CRO) industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. For more information, please visit www.acrohealth.org.
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers. For more details visit their website at: www.currentpartnering.com
General Biologic is an information, research, and advisory firm focused on China's pharmaceutical, biotechnology and healthcare industries. Based in Shanghai, GB helps companies and investors understand and act on opportunities in China. GB is the publisher of China Pharmaceutical & Biotechnology Monthly, industry reports, databases, and audio interviews with leaders in China's healthcare industry.
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting in- and out-licensing activities, Pharmalicensing provides partnering services, business development reports, industry news and a jobs source for candidates and employers.
Pharmalicensing is used by over 90,000 users per month and is a division of UTEK Corporation. Visit www.pharmalicensing.com
Biocompare (www.biocompare.com) is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit Biocompare to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news.
ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access. See www.ThePharmYard.com
Mailing List
